Myer's hopes of acquiring Premier Investments' Apparel Brands received a boost after an independent expert found the proposed ...

Battery technology company Novonix has raised $32.3 million in a heavily-oversubscribed share purchase plan for eligible retail shareholders.

Neuren Pharmaceuticals' Rett syndrome treatment, trofinetide, is a step closer to receiving regulatory approval in the ...

Morningstar has lifted its fair value estimate on Telix Pharmaceuticals but says the stock is overvalued a day after the company upgraded its full-year revenue guidance.